# Michael H. Weisman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-h-weisman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,616 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 94 |
| i10-index | 308 |
| Last Known Institution | Stanford Medicine |
| OpenAlex ID | https://openalex.org/A5030335777 |
| ORCID iD | https://orcid.org/0000-0001-5568-388X |
| Works | 537 |

## Researcher papers

- [Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/infliximab-and-methotrexate-in-the-treatment-of-rheumatoid-arthritis/)
- [Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial](https://scholariq.org/papers/infliximab-chimeric-anti-tumour-necrosis-factor-monoclonal-antibody-versus/)
- [The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment](https://scholariq.org/papers/the-premier-study-a-multicenter-randomized-double-blind-clinical-trial-of/)
- [Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis](https://scholariq.org/papers/glucosamine-chondroitin-sulfate-and-the-two-in-combination-for-painful-knee/)
- [Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis](https://scholariq.org/papers/mycophenolate-mofetil-or-intravenous-cyclophosphamide-for-lupus-nephritis/)
- [Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)](https://scholariq.org/papers/sustained-benefits-of-infliximab-therapy-for-dermatologic-and-articular/)
- [Transancestral mapping and genetic load in systemic lupus erythematosus](https://scholariq.org/papers/transancestral-mapping-and-genetic-load-in-systemic-lupus-erythematosus/)
- [Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis](https://scholariq.org/papers/rituximab-as-therapy-to-induce-remission-after-relapse-in-anca-associated/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

## Researcher university

- [Stanford Medicine](https://scholariq.org/institutions/stanford-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.